Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Immunotherapy advances·2022
Same author

Historical and new insights into pathogenesis of type 1 diabetes (2).

Clinical and experimental immunology·2021
Same author

Referral rates of patients with diabetes to secondary care are inversely related to the prevalence of diabetes in each primary care practice and confidence in treatment, not to HbA1c level.

Primary care diabetes·2021
Same author

Identifying the 'Achilles heel' of type 1 diabetes.

Clinical and experimental immunology·2020
Same author

Historical and new insights into pathogenesis of type 1 diabetes.

Clinical and experimental immunology·2019
Same author

Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot.

Journal of immunological methods·2019

Related Experiment Video

Updated: Jun 8, 2026

Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

S I Mannering1, F S Wong, I Durinovic-Belló

  • 1St Vincent's Institute, The University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Vic, Australia. smannering@svi.edu.au

Clinical and Experimental Immunology
|September 18, 2010
PubMed
Summary

Type 1 diabetes (T1D) research needs better ways to measure T cells. Developing standardized assays is crucial for understanding T1D causes and guiding new therapies.

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

Related Experiment Videos

Last Updated: Jun 8, 2026

Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmune Diseases

Background:

  • Type 1 diabetes (T1D) is an autoimmune condition where T cells destroy insulin-producing beta cells.
  • Current methods for analyzing T cells in T1D lack standardization and broad acceptance.
  • Accurate T cell analysis is vital for understanding T1D pathogenesis and developing effective treatments.

Purpose of the Study:

  • To review current assays for detecting autoreactive T cells in human blood related to T1D.
  • To critically evaluate the strengths and weaknesses of existing T cell detection methods.
  • To discuss challenges and future directions for T cell assays in T1D research.

Main Methods:

  • Literature review of existing T cell assays for Type 1 diabetes.
  • Critical analysis of assay methodologies, including sensitivity, specificity, and reproducibility.
  • Discussion of current challenges in T cell functional analysis for T1D.

Main Results:

  • No single, widely accepted standardized assay currently exists for analyzing T cell function in T1D.
  • Various assays show promise but have limitations in standardization and application.
  • Significant challenges remain in developing reliable tools for T cell assessment in T1D.

Conclusions:

  • Standardized assays for autoreactive T cells are urgently needed for T1D research.
  • Improved T cell assays will facilitate a deeper understanding of T1D and guide therapeutic development.
  • Future research should focus on developing and validating robust, standardized T cell assays for T1D.